Enable JavaScript to ensure website accessibility
Precipio, Inc. Announces Adjournment of Annual Meeting of Stockholders

New Shareholders Meeting Date: Friday, June 21 at 9 a.m. Eastern Time. NEW HAVEN, CT, [...]

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

The cost of a rescheduled shareholder meeting could reach $100,000 NEW HAVEN, CT, (June 12th, [...]

Precipio Provides Status Update on Current Business Matters

NEW HAVEN, CT, (June 12th, 2024) – Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) provides [...]

Precipio Secures a short-term $500K Credit Facility

Loan will supplement any temporary cashflow deficit related to cash collections delay due to Change [...]

Precipio Announces Year end 2023 Shareholder Update Call

Conference Call to be held on April 1st, 2024 at 5:00 PM EST NEW HAVEN, [...]

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Company continues to make strides towards breakeven NEW HAVEN, CT, Globenewswire – (February 13, 2024) – [...]

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

NEW HAVEN, CT, Globenewswire – (February 6, 2024) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: [...]

Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Results clearly demonstrate the business’s ability to reach breakeven in the near future NEW HAVEN, [...]

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

First order for IV-Cell placed by Major Japanese Laboratory NEW HAVEN, CT, Globenewswire – (January [...]

Precipio Announces Christina Valauri joins the Board of Directors

Douglas Fisher, MD will step down as Director, and remain as a board observer NEW [...]